5-Chloro-2-methoxyphenylboronic acid

We are 5-Chloro-2-methoxyphenylboronic acid CAS:89694-48-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 5-Chloro-2-methoxyphenylboronic acid
Other Name:
5-Chloro-2-methoxyphenylboronic acid
(5-chloro-2-methoxyphenyl)boronic acid
CAS No: 89694-48-4
MF: C7H8BClO3
MW: 186.40100
Density: 1.32 g/cm3
Boiling point: 360.2ºC at 760 mmHg
Melting point: 134-141 °C(lit.)
Flash point: 171.6ºC
Refractive index: 1.544
UN Number: Non-dangerous goods
Transport hazard class: Non-dangerous goods
Packing group: Non-dangerous goods
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

5-Chloro-2-methoxyphenylboronic acid


Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter.2-Methoxy-4-nitroaniline CAS:97-52-9 Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.2-Propoxyethanol Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.6-Bromonicotinic acid Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.

Related Products
Product Name
4-METHOXYBENZYL ISOTHIOCYANATE View Details
2-Methylimidazole View Details
3-Boronobenzoic acid View Details
6-hydroxynicotinic acid manufacturer 1,1,2,2,9,9,10,10-Octafluoro[2.2]paracyclophane Cas:3345-29-7 manufacturer 5-methoxybenzo[b][1]benzazepine-11-carbonyl chloride manufacturer 5-Chloro-2,4-Difluoroaniline manufacturer N-(4-Methylthiazol-2-yl)acetamide manufacturer